期刊文献+

肾间质纤维化中MicroRNA表达研究进展 被引量:3

Progress of MicroRNA Expression in Renal Interstitial Fibrosis
下载PDF
导出
摘要 MicroRNA(miRNA)是一种高度保守、内源性的非编码小分子RNA,主要参与生物体中转录后水平基因表达的调控。miRNAs在各种肾脏疾病的发病机制中起重要作用。肾间质纤维化是各种慢性肾脏病进展至终末期,最终导致器官功能丢失的共同的病理过程和特征。转化生长因子β(TGF-β)在肾纤维化过程中是公认的一个重要的介质,它能刺激细胞外基质(ECM)的积聚并损害肾功能。近年研究发现,在肾脏组织中存在的一些miRNAs对肾脏纤维化的发生与发展有着重要的作用,深入地了解它们之间的关系可以为临床肾脏纤维化的治疗提供新的治疗靶点。 MicroRNA( miRNA) is a highly conserved,endogenous non encoding small molecule RNA,which is mainly involved in the regulation of the expression of the gene in the organism. MiRNAs plays an important role in the pathogenesis of various renal diseases. Renal interstitial fibrosis is a common pathological process and characteristics of chronic kidney disease progression to the end,resulting in the loss of organ function.Transforming growth factor beta( TGF-β) is an important medium in renal fibrosis,which can stimulate the accumulation of extracellular matrix( ECM) and impair renal function. In recent years,some studies have found that some of the miRNAs in the kidney tissue has an important role in the occurrence and development of renal fibrosis. The understanding of relationship between them could provide a new therapeutic target for the treatment of renal fibrosis.
出处 《标记免疫分析与临床》 CAS 2016年第3期344-347,共4页 Labeled Immunoassays and Clinical Medicine
关键词 MICRORNA 肾疾病 肾纤维化 TGF-β信号 MicroRNA Renal disease Renal fibrosis TGF-beta
  • 相关文献

参考文献1

二级参考文献14

  • 1Barrel DP. MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136: 215-233.
  • 2Bauersachs J. Regulation of myocardial fibrosis by microRNAs. J Cardiovasc Pharmacol, 2010, 56: 454-459.
  • 3Noetel A, Kwiecinski M, Elfimova N, et al. microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol, 2012, 3: 49.
  • 4Ho J, Kreidberg JA. The long and short of microRNAs in the kidney. J Am Soe Nephrol, 2012, 23: 400-404.
  • 5Zarjou A, Yang S, Abraham E, et al. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol, 2011, 301: F793-F801.
  • 6Xiong M, Jiang L, Zhou Y, et al. The miR-200 family regulates TGF-betal -induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol, 2012, 302: F369-F379.
  • 7Chung AC, Huang XR, Meng X, et al. miR-192 mediates TGF-beta/Smad3-drivert renal fibrosis. J Am Soc Nephrol, 2010, 21: 1317-1325.
  • 8Wang B, Komers R, Carew R, et al. Suppression of microRNA-29 expression by TGF-betal promotes collagen expression and renal fibrosis. J Am Soc Nephrol, 2012, 23: 252-265.
  • 9Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int, 1993, 44: 411-422.
  • 10Krupa A, Jenkins R, Luo DD, et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol, 2010, 21: 438-447.

共引文献6

同被引文献25

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部